Genus Capital Management’s GSK GSK Stock Holding History

Genus Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$640K	Sell	12,210 -300	-2%	-$15.9K	0.06%	158
2026 Q1	$690K	Buy	12,510 +430	+4%	+$23.3K	0.08%	146
2025 Q4	$592K	Buy	12,080 +2,520	+26%	+$118K	0.07%	143
2025 Q3	$413K	Buy	9,560 +220	+2%	+$8.59K	0.05%	163
2025 Q2	$359K	Sell	9,340 -470	-5%	-$18K	0.05%	153
2025 Q1	$380K	Buy	+9,810	New	+$359K	0.06%	149
2024 Q2	–	Sell	-9,245	Closed	-$389K	–	278
2024 Q1	$396K	Buy	+9,245	New	+$381K	0.05%	168
2023 Q4	–	Sell	-14,350	Closed	-$515K	–	270
2023 Q3	$520K	Hold	14,350	–	–	0.08%	148
2023 Q2	$511K	Buy	+14,350	New	+$515K	0.08%	160

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Genus Capital Management's GSK Position: Q2 2026 in Review

Genus Capital Management reduced its GSK (GSK) stake by 2.4% in Q2 2026, selling an estimated $15.9K and leaving 12,210 shares worth $640K. The position accounts for 0.06% of the portfolio, ranked #158.

Genus Capital Management first reported a position in GSK in Q2 2023 and has held it in 9 quarters since. The position peaked at $690K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Genus Capital Management held 12,210 shares of GSK worth $640K as of Q2 2026.
Genus Capital Management sold 300 GSK shares in Q2 2026, an estimated $15.9K.
GSK made up 0.06% of Genus Capital Management's portfolio in Q2 2026, its #158 holding.
Genus Capital Management first reported a position in GSK in Q2 2023 and has held it in 9 quarters since.
Genus Capital Management's GSK position peaked at $690K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.